Guggenheim Reaffirms “Buy” Rating for Birkenstock (NYSE:BIRK)

Birkenstock (NYSE:BIRKGet Free Report)‘s stock had its “buy” rating reissued by stock analysts at Guggenheim in a report released on Friday,Benzinga reports. They presently have a $60.00 price objective on the stock. Guggenheim’s price target indicates a potential upside of 50.88% from the company’s previous close.

A number of other research analysts have also recently weighed in on the stock. Raymond James Financial started coverage on shares of Birkenstock in a report on Wednesday, July 1st. They issued an “outperform” rating and a $52.00 price objective for the company. Wall Street Zen raised shares of Birkenstock from a “sell” rating to a “hold” rating in a research report on Saturday, August 1st. JPMorgan Chase & Co. upped their price objective on Birkenstock from $49.00 to $58.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 4th. Stifel Nicolaus set a $51.00 price objective on Birkenstock in a research note on Wednesday, May 13th. Finally, UBS Group decreased their target price on Birkenstock from $77.00 to $76.00 and set a “buy” rating for the company in a report on Tuesday, August 4th. Thirteen research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Birkenstock currently has a consensus rating of “Moderate Buy” and a consensus target price of $53.28.

Check Out Our Latest Stock Analysis on Birkenstock

Birkenstock Price Performance

BIRK stock opened at $39.77 on Friday. The business’s fifty day moving average price is $43.10 and its 200 day moving average price is $40.09. Birkenstock has a 12-month low of $31.12 and a 12-month high of $53.53. The company has a current ratio of 2.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $7.31 billion, a PE ratio of 17.95, a P/E/G ratio of 1.54 and a beta of 1.30.

Birkenstock (NYSE:BIRKGet Free Report) last announced its earnings results on Wednesday, May 13th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.12). The firm had revenue of $714.40 million for the quarter, compared to analysts’ expectations of $716.62 million. Birkenstock had a net margin of 16.26% and a return on equity of 12.95%. The business’s revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.63 earnings per share. On average, sell-side analysts anticipate that Birkenstock will post 2.27 EPS for the current year.

Insider Buying and Selling at Birkenstock

In other news, insider Mehdi Nico Bouyakhf sold 30,000 shares of the company’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $43.50, for a total value of $1,305,000.00. Following the completion of the transaction, the insider owned 31,153 shares in the company, valued at approximately $1,355,155.50. This represents a 49.06% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Institutional Investors Weigh In On Birkenstock

Institutional investors and hedge funds have recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. grew its holdings in shares of Birkenstock by 11.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 11,886,454 shares of the company’s stock worth $486,156,000 after purchasing an additional 1,264,841 shares during the last quarter. Bamco Inc. NY increased its position in shares of Birkenstock by 25.4% during the fourth quarter. Bamco Inc. NY now owns 7,966,037 shares of the company’s stock worth $325,811,000 after purchasing an additional 1,612,236 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Birkenstock by 30.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,049,787 shares of the company’s stock valued at $145,078,000 after purchasing an additional 956,167 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Birkenstock by 0.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,950,380 shares of the company’s stock valued at $120,672,000 after purchasing an additional 25,585 shares during the last quarter. Finally, Morgan Stanley boosted its position in shares of Birkenstock by 25.1% in the 4th quarter. Morgan Stanley now owns 2,797,719 shares of the company’s stock valued at $114,427,000 after purchasing an additional 562,188 shares during the period. 19.93% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Birkenstock

Here are the key news stories impacting Birkenstock this week:

  • Positive Sentiment: Revenue beat and guidance increase: Fiscal third-quarter revenue rose roughly 13% year over year to approximately €719.5 million, or $821 million, exceeding analyst expectations. Management raised its full-year revenue-growth forecast, citing strong demand and continued full-price selling. Birkenstock raises annual revenue forecast on strong demand
  • Positive Sentiment: Direct-to-consumer momentum: Revenue growth reached 15% on a constant-currency basis, led by the direct-to-consumer channel. New styles, pricing power and demand for sandals supported the quarter, while management pointed to potential global interest in its emerging ballerina trend. Birkenstock keeps its footing as new styles and pricing power drive growth
  • Positive Sentiment: Analyst support: BTIG Research reaffirmed its “buy” rating and assigned a $60 price target, implying substantial upside from the reference price. This reinforces the bullish view following the results. BTIG Research rating update
  • Neutral Sentiment: Profitability was slightly below expectations: Quarterly earnings of approximately $0.85–$0.86 per share narrowly missed consensus estimates of $0.86–$0.87, although earnings increased from the prior-year period. Full-year EPS guidance of $2.22–$2.40 brackets the current analyst consensus of $2.27.
  • Negative Sentiment: Valuation remains a consideration: Some analysts view Birkenstock as less attractive at its current valuation despite the strong DTC acceleration, which could limit further gains if growth slows or consumer demand weakens. Birkenstock: Fantastic DTC Acceleration, But Not the Best Deal

Birkenstock Company Profile

(Get Free Report)

Birkenstock Group AG, listed on the New York Stock Exchange under the symbol BIRK, is a global footwear manufacturer renowned for its anatomically contoured footbeds and iconic sandal designs. The company’s core product lines include classic models such as the Arizona, Boston and Madrid, alongside a range of clogs, shoes and orthotic insoles. In addition to footwear, Birkenstock offers complementary accessories, including socks and leather care products, reinforcing its commitment to foot health and comfort.

Birkenstock reaches consumers through a diversified distribution network that combines direct-to-consumer channels—such as branded retail stores and e-commerce platforms—with wholesale partnerships spanning specialty footwear retailers, department stores and select online marketplaces.

Further Reading

Analyst Recommendations for Birkenstock (NYSE:BIRK)

Receive News & Ratings for Birkenstock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Birkenstock and related companies with MarketBeat.com's FREE daily email newsletter.